Doctor Spyridon Maragkoudakis
General Hospital St. George, Chania (Greece)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
The potential protective effect of dapagliflozin on the development of cardiotoxicity in cancer patients after one year of observation.
Event: ESC Congress 2024
Topic: Antidiabetic Pharmacotherapy
Session: Real-world evidence on the cardiovascular effects of therapies for diabetes
The potentially protective effect of dapagliflozin on the development of cardiotoxicity in cancer patients
Event: ESC Congress 2023
Topic: Cardio-Oncology
Session: Cardiotoxicity: mechanisms, biomarkers, and treatment
